The European Medicines Agency and the Dutch government hope to sign the “Seat Agreement” that will kick off the next stage of the agency’s Brexit-induced relocation process on July 1. The agreement is intended to allow the EMA to function properly and independently once it relocates from London to the Dutch capital Amsterdam in the first quarter of 2019.
The text of the agreement was finalized towards the end of April. It will enter into force as soon as...